Scholars Central

Short communicationPublished 30 Jul 2022

Stem cell research 2017 : Analysis of outcomes following mesenchymal stem cell therapy in subjects with musculoskeletal conditions_ brian m mehling_trauma surgeon, Harvard university

Authors: Brian M Mehling

Journal of Cell and Developmental Biology

Volume 6 · Issue 4 · Pages 002

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Musculoskeletal conditions are major public health problems and often associated with reduced function and pain. Musculo skeletal lrelated pain is affecting more than one third of the adult population worldwide. Pain reduction is one of the main outcomes to determine the success of therapy of subjects with most common orthopedic conditions. Inflammation plays an important role in the occurrence of acute and chronic musculoskeletal-related pain. Numerous investigations suggest that Mesenchymal Stem Cells (MSCs) represent a valuable tool for therapy of inflammation and regeneration of tissue damage. BHI Therapeutic Sciences offers a novel method of arthritis therapy using a patient’s own stromal vascular fraction (SVF) cells including MSCs. The therapy is available at Malacky Hospital in Slovakia. Blue Horizon International Slovakia is licensed by the Ministry of Health of Slovak Republic to provide adipose stem cell therapies for orthopedic joint applications - knees, hips, shoulders, and ankles. Procedures utilize cutting edge technology and adult stem cells only. Results from patients’ follow-up examinations and MRI scans showed that stem cell therapy was safe for the patients. Followup examination results conducted 10 days, 3 and 6 months after therapy have shown significant improvement of clinical condition relating to pain relief, improved mobility, which was shown also on the follow-up MRI scans of the affected joints.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell and Developmental Biology
  • SubjectBiology
  • BylineArticles whose byline prints “Brian M Mehling”